TY - JOUR
T1 - Manifesto for a European research network into Problematic Usage of the Internet
AU - COST Action Network
AU - Fineberg, N. A.
AU - Demetrovics, Z.
AU - Stein, D. J.
AU - Ioannidis, K.
AU - Potenza, M. N.
AU - Grünblatt, E.
AU - Brand, M.
AU - Billieux, J.
AU - Carmi, L.
AU - King, D. L.
AU - Grant, J. E.
AU - Yücel, M.
AU - Dell'Osso, B.
AU - Rumpf, H. J.
AU - Hall, N.
AU - Hollander, E.
AU - Goudriaan, A.
AU - Menchon, J.
AU - Zohar, J.
AU - Burkauskas, J.
AU - Martinotti, G.
AU - Van Ameringen, M.
AU - Corazza, O.
AU - Pallanti, S.
AU - Chamberlain, S. R.
N1 - Funding Information:
This publication is based upon work from COST Action CA16207 “European Network for Problematic Usage of the Internet”, supported by COST (European Cooperation in Science and Technology: www.cost.eu ). The publication is also based on work supported by the European College of Neuropsychopharmacology Networks and the International College of Obsessive Compulsive Spectrum Disorders. Dr Chamberlain's involvement in this project was supported by a Clinical Fellowship from the Wellcome Trust (UK; 110 049/Z/15/Z ). Zsolt Demetrovics acknowledges the support of the Hungarian National Research, Development and Innovation Office (Grant numbers: K111938 , KKP126835 ). Dr. Ioannidis involvement was supported by Health Education East of England Higher Training Special Interest sessions. Dr. Potenza's involvement was supported by the National Center for Responsible Gaming through a Center of Excellence grant, the Connecticut Council on Problem Gambling and the Connecticut Department of Mental Health and Addiction Services. Dr. King's involvement was supported by a Discovery Early Career Researcher Award (DECRA) DE170101198 funded by the Australian Research Council (ARC). The funding agencies did not have input into the content of the manuscript and the views described in the manuscript reflect those of the authors and not necessarily those of the funding agencies. Dr. Yucel was supported by a National Health and Medical Research Council of Australia Fellowship (# APP1117188 ) and the David Winston Turner Endowment Fund .
Funding Information:
In the past year, NF has received research support from European College of Neuropsychopharmacology (ECNP), National Institute for Health Research, Wellcome Foundation. Dr Fineberg has received honoraria for lectures at scientific meetings from Abbott, Wiley, Sun Pharmaceutical Industries, and British Association for Psychopharmacology (BAP). Dr Fineberg has received financial support to attend scientific meetings from the International Society for Affective Disorders, International Forum of Mood and Anxiety Disorders, ECNP, BAP and Royal College of Psychiatrists. Dr Fineberg has received financial royalties for publications from Oxford University Press and payment for editorial duties from Taylor and Francis. Dr Chamberlain receives an editorial fee from Elsevier in his capacity as associate editor at Neuroscience and Biobehavioral Reviews (NBBR). Dr Chamberlain consults for Cambridge Cognition and Shire. Dr. Hollander has received research grants in the past year from Department of Defense (DOD), Orphan Products Division of Food and Drug Administration (FDA), Roche, Curemark, Takeda, Avanir, and Neurocrine, Dr. Pallanti has received research grant in the past and current year from National Institute of Mental Health (NIMH) for a R21 on Theta Burst Stimulation in Gambling Disorder. Dr. Dell’ Osso has received research grants in the past year from Angelini, Lundbeck and FB Health. Dr. Potenza has consulted for and advised Rivermend Health, Opiant/Lakelight Therapeutics and Jazz Pharmaceuticals; received research support (to Yale) from the Mohegan Sun Casino and the National Center for Responsible Gaming; consulted for or advised legal and gambling entities on issues related to impulse control and addictive behaviours; provided clinical care related to impulse control and addictive behaviours; performed grant reviews; edited journals/journal sections; given academic lectures in grand rounds, CME events and other clinical/scientific venues; and generated books or chapters for publishers of mental health texts. In the past 3 years, Dr. Stein has received research grants and/or consultancy honoraria from Biocodex, Lundbeck, Servier, and Sun. Joseph Zohar has received grant/research support from Lundbeck, Servier, Brainsway and Pfizer, has served as a consultant or on advisory boards for Servier, Pfizer, Abbott, Lilly, Actelion, AstraZeneca and Roche, and has served on speakers’ bureaus for Lundbeck, Roch, Lilly, Servier, Pfizer and Abbott. Dr. Grant has received research grants from TLC Foundation for Body Focused Repetitive Behaviors, NIAAA, and Takeda Pharmaceuticals. Dr. Burkauskas has served as a scientific consultant to CogState, Ltd. In the past 24 months, Dr. Van Ameringen has been on the Advisory Boards of Purdue, Allergan and Lundbeck, and Speaker's Bureau for Purdue, Allergan, Lundbeck and Pfizer and has received research support from Janssen-Ortho Inc, Pfizer and the Hamilton Academic Health Sciences Organization (HAHSO) Innovation Grant (AFP Innovation Grant). Dr Yucel has received funding from law firms in relation to expert witness reports/statements; no funding was received in relation to the present article. The other authors report no disclosures.
Publisher Copyright:
© 2018 The Authors
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/11
Y1 - 2018/11
N2 - The Internet is now all-pervasive across much of the globe. While it has positive uses (e.g. prompt access to information, rapid news dissemination), many individuals develop Problematic Use of the Internet (PUI), an umbrella term incorporating a range of repetitive impairing behaviours. The Internet can act as a conduit for, and may contribute to, functionally impairing behaviours including excessive and compulsive video gaming, compulsive sexual behaviour, buying, gambling, streaming or social networks use. There is growing public and National health authority concern about the health and societal costs of PUI across the lifespan. Gaming Disorder is being considered for inclusion as a mental disorder in diagnostic classification systems, and was listed in the ICD-11 version released for consideration by Member States (http://www.who.int/classifications/icd/revision/timeline/en/). More research is needed into disorder definitions, validation of clinical tools, prevalence, clinical parameters, brain-based biology, socio-health-economic impact, and empirically validated intervention and policy approaches. Potential cultural differences in the magnitudes and natures of types and patterns of PUI need to be better understood, to inform optimal health policy and service development. To this end, the EU under Horizon 2020 has launched a new four-year European Cooperation in Science and Technology (COST) Action Programme (CA 16207), bringing together scientists and clinicians from across the fields of impulsive, compulsive, and addictive disorders, to advance networked interdisciplinary research into PUI across Europe and beyond, ultimately seeking to inform regulatory policies and clinical practice. This paper describes nine critical and achievable research priorities identified by the Network, needed in order to advance understanding of PUI, with a view towards identifying vulnerable individuals for early intervention. The network shall enable collaborative research networks, shared multinational databases, multicentre studies and joint publications.
AB - The Internet is now all-pervasive across much of the globe. While it has positive uses (e.g. prompt access to information, rapid news dissemination), many individuals develop Problematic Use of the Internet (PUI), an umbrella term incorporating a range of repetitive impairing behaviours. The Internet can act as a conduit for, and may contribute to, functionally impairing behaviours including excessive and compulsive video gaming, compulsive sexual behaviour, buying, gambling, streaming or social networks use. There is growing public and National health authority concern about the health and societal costs of PUI across the lifespan. Gaming Disorder is being considered for inclusion as a mental disorder in diagnostic classification systems, and was listed in the ICD-11 version released for consideration by Member States (http://www.who.int/classifications/icd/revision/timeline/en/). More research is needed into disorder definitions, validation of clinical tools, prevalence, clinical parameters, brain-based biology, socio-health-economic impact, and empirically validated intervention and policy approaches. Potential cultural differences in the magnitudes and natures of types and patterns of PUI need to be better understood, to inform optimal health policy and service development. To this end, the EU under Horizon 2020 has launched a new four-year European Cooperation in Science and Technology (COST) Action Programme (CA 16207), bringing together scientists and clinicians from across the fields of impulsive, compulsive, and addictive disorders, to advance networked interdisciplinary research into PUI across Europe and beyond, ultimately seeking to inform regulatory policies and clinical practice. This paper describes nine critical and achievable research priorities identified by the Network, needed in order to advance understanding of PUI, with a view towards identifying vulnerable individuals for early intervention. The network shall enable collaborative research networks, shared multinational databases, multicentre studies and joint publications.
UR - http://www.scopus.com/inward/record.url?scp=85054098852&partnerID=8YFLogxK
U2 - 10.1016/j.euroneuro.2018.08.004
DO - 10.1016/j.euroneuro.2018.08.004
M3 - Journal articles
C2 - 30509450
AN - SCOPUS:85054098852
SN - 0924-977X
VL - 28
SP - 1232
EP - 1246
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
IS - 11
ER -